2011 ADA Posters 1261-2041.indd - Diabetes
2011 ADA Posters 1261-2041.indd - Diabetes
2011 ADA Posters 1261-2041.indd - Diabetes
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Integrated Physiology/<br />
Obesity<br />
POSTERS<br />
prevented the THAP- and TUNI-induced decreases in insulin-stimulated<br />
IRS1 Y 612 phosphorylation and glucose uptake. These data suggest a novel<br />
paradigm where ER stress enhances TRB3 expression leading to insulin<br />
resistance in skeletal muscle. <strong>ADA</strong>-Funded Research<br />
& 1715-P<br />
Effects of Muscle Specifi c Deletion of Carnitine Palmitoyltransferase<br />
and Carnitine Acetyltransferase on Fuel Selection<br />
JINGYING ZHANG, ROBERT C. NOLAN, SARAH E. SEILER, TIMOTHY R. KOVES,<br />
INDU KHETERPAL, ROBERT D. STEVENS, OLGA R. ILKAYEVA, DEBORAH M.<br />
MUOIO, RANDALL L. MYNATT, Baton Rouge, LA, Durham, NC<br />
Mitochondrial fatty acid import and oxidation is initiated by carnitine<br />
palmitoyltransferase-I (CPTI). CPTI is located in the outer mitochondrial<br />
membrane and catalyzes the formation of long chain acyl-carnitines from<br />
carnitine and acyl-CoA. Short chain acyl-carnitines are formed via the<br />
activity of carnitine acetyltransferase (CrAT) in the mitochondrial matrix.<br />
Even though CrAT’s role is not completely understood, it is thought to buffer<br />
acetyl-CoA/CoA in the mitochondria. To understand the role of each enzyme<br />
in energy homeostasis, substrate utilization and insulin sensitivity; mice<br />
were generated with muscle specifi c deletion of CPT-I m-/- and CrAT m-/- . CPT-<br />
I m-/- and CrAT m-/- mice have normal body weight, fat mass, fat free mass,<br />
energy expenditure and food intake. However, long chain fatty acid oxidation<br />
is greatly reduced in muscle homogenates and isolated mitochondria<br />
from CPT-I m-/- mice. Given the popular hypothesis that impaired fatty acid<br />
oxidation in skeletal muscle causes the accumulation of lipid intermediates<br />
leading to insulin resistance, we paradoxically observed improved GTT<br />
and ITT in CPT-I m-/- mice relative to control mice. Metabolic chamber data<br />
demonstrated that CPT-I m-/- mice oxidize more carbohydrate than control<br />
mice. Conversely, CrAT m-/- mice had impaired GTT and ITT relative to control<br />
mice. Metabolic chamber data revealed no difference in 24 hour RER<br />
between CrAT m-/- and control mice, but there is impaired switching from<br />
fatty acid oxidation to carbohydrate oxidation during the transition from a<br />
fasted to fed state. In vitro studies in muscle homogenates and isolated<br />
mitochondria demonstrated that the addition of carnitine increased PDH<br />
activity and the complete oxidation of pyruvate in control mice but not CrAT<br />
m-/- mice. In addition, the ability of pyruvate to suppress fatty acid oxidation<br />
was blunted in mitochondria from CrAT m-/- mice. Together our data indicate<br />
that, the loss of skeletal muscle CPTI results in reduced oxidization of long<br />
chain fatty acids and stimulates glucose oxidation, whereas the loss of CrAT<br />
in muscle predominately affects metabolic fl exibility.<br />
Supported by: NIH <strong>ADA</strong>-Funded Research<br />
& 1716-P<br />
<strong>Diabetes</strong> Mellitus Impact on Left Ventricular Myocardial Structure<br />
and Function in Aortic Stenosis before Valve Replacement<br />
INÊS FALCÃO-PIRES, NAZHA HAMDANI, CRISTINA GAVINA, JOLANDA VAN DER<br />
VELDEN, ATTILA BORBÉLY, HANS NIESSEN, GER STIENEN, ADELINO F. LEITE-<br />
MOREIRA, WALTER J. PAULUS, Porto, Portugal, Amsterdam, The Netherlands,<br />
Debrecen, Hungary, Amsterdam, Portugal<br />
<strong>Diabetes</strong> mellitus (DM) is an independent risk factor for progression of<br />
aortic valve stenosis (AS) and signifi cantly impacts longterm outcome after<br />
valve replacement. High incidence of residual heart failure may account<br />
for this prognosis. We aimed to assess the impact of DM on diastolic (dys)<br />
function of AS patients.<br />
Patients with severe isolated AS (n=46) and AS plus type-II diabetes<br />
(AS-DM + ,n=16) with preserved left ventricular (LV) ejection fraction and<br />
no clinical or angiographic signs of coronary artery disease were studied.<br />
Doppler echocardiographic data was used to compare in vivo LV function.<br />
Biopsies were used to assess fi brosis, cardiomyocyte hypertrophy<br />
(MyD), advanced glycation endproducts (AGEs) and phosphorylation of<br />
myofi lamentary proteins. Isolated and permeabilized cardiomyocytes were<br />
used to measure active force (F active ), resting force (F passive ) and myofi lament<br />
calcium sensitivity(pCa 50 ).<br />
In isolated AS, LV deceleration time and end-diastolic pressure were<br />
augmented (239±19ms; 21.4±1.4mmHg, respectively) and the latter<br />
signifi cantly correlated with increased fi brosis (12.9±1.1%; r=0.40,p=0.04)<br />
and MyD (22.9±0.5μm; r=0.60, p